FDA Adverse Event Injury Summary report: N

ACTIVA

MDR report key: 2950856 · Received February 8, 2013

Report

Report Number
3007566237-2013-00431
Event Type
Injury
Date Received
February 8, 2013
Date of Event
September 1, 2012
Report Date
January 17, 2013
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

THE ACTUAL EVENT DATES WERE NOT PROVIDED. THIS DATE IS BASED ON THE DATE OF PUBLICATION OF THE ARTICLE. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS. PRODUCT ID: NEU_UNKNOWN_LEAD, SERIAL# UNKNOWN, PRODUCT TYPE: LEAD. (B)(4).

Description of Event or Problem · 1

HAMANI, C., GIACOBBE, P., DIWAN, M., BALBINO, E., TONG, J., BRIDGMAN, A., LIPSMAN, N., LOZANO, A. M., KENNEDY, S. H., NOBREGA, J. N. MONOAMINE OXIDASE INHIBITORS POTENTIATE THE EFFECTS OF DEEP BRAIN STIMULATION. AMERICAN JOURNAL OF PSYCHIATRY. 2012;169(12):1320-13 21. DOI: 10.1176/APPI.AJP.2012.12060754. SUMMARY: THE AUTHORS PROVIDE CLINICAL AND PRECLINICAL EVIDENCE SUGGESTING THAT THE EFFECTS OF DBS MAY BE POTENTIATED BY THE CO-ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS (MAOIS). THE CASE STUDY HIGHLIGHTS THE EFFECTS ON A 35-YEAR-OLD MAN DIAGNOSED WITH DEPRESSION. REPORTED EVENT: A 35 YEAR OLD MALE EXPERIENCED A LOSS OF THERAPEUTIC EFFECT FOUR YEARS AFTER DBS IMPLANT. REPROGRAMMING DID NOT RESOLVE THE ISSUE. THE IMPLANTABLE NEUROSTIMULATOR WAS REPLACED WITHOUT A NOTICEABLE IMPROVEMENT IN DEPRESSION. THE PATIENT WAS GIVEN TRANYLCYPROMINE, 40 MG ORALLY, TWICE A DAY, ALONGSIDE DBS (2.5 V, 90 'S, 130 HZ,1- 5- C+). AFTER THE MEDICATION CHANGE, THE PATIENT'S DEPRESSION IMPROVED MARKEDLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
54992 ACTIVA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR

Patients

Seq Age Sex Outcome Treatment
1 00035 YR Required Intervention